Vapers Digest 1st December

Wednesday’s News at a glance:

Justice Kavanaugh Asks FDA to Respond to Breeze Smoke Emergency Stay Application

Jonathan H. Adler, Reason

Yesterday, Justice Brett Kavanaugh requested that the federal government file a response to Breeze Smoke LLC’s application for an emergency stay to block the Food and Drug Administration’s order denying approval of the manufacturer’s flavored vaping products. I noted Breeze Smoke’s application in this post last week. The government’s response is due December 6. The case docket is here.

Anti-Vape Groups Ask Judge Grimm to Monitor FDA’s PMTA Progress

Jim McDonald, Vaping 360

Plaintiffs in the lawsuit that changed the submission deadline for Premarket Tobacco Applications (PMTAs) have asked the federal judge in that case to demand the FDA regularly report on its PMTA review process.


TWO from Dave Cross, Planet of the Vapes

sCOPe Launches Online Library

sCOPe, a global collaboration of tobacco harm reduction groups has launched an extensive tobacco harm reduction online library of streamed panel discussions and presentations. sCOPe includes leading THR associations CASAA (Consumer Advocates for Smoke-Free Alternatives Association) in the United States, ARDT Iberoamerica in Latin America, and CAPHRA (Coalition of Asia Pacific Tobacco Harm Reduction Advocates).

Knowledge Is Key For Politicians

Knowledge of e-cigarettes is key to European Parliament support, according to market experts ECigIntelligence and TobaccoIntelligence. The two bodies are the leading providers of detailed global market and regulatory analysis, legal tracking, and quantitative data for the e-cigarette, heated tobacco and combustible-alternatives sector worldwide.

Discontinuation of Varenicline may boost e-cigarettes use as alternative nicotine replacement therapy

Catania Conversation

High levels of cancerogenic nitrosamines have been recently found in the smoking cessation medicine Varenicline (Champix). As a precautionary measure, the drug has been withdrawn from the market and its distribution halted in June.

The Medicines and Healthcare products Regulatory Agency (MHRA), a Department of Health and Social Care in the United Kingdom, and the European Medicines Agency (EMA) have issued a supply distribution alert for Champix and initiated the drug recall.

Tobacco Intelligence

The use of traditional tobacco products has been in decline across the EU in recent decades, and with the growth of new novel nicotine products it is expected to decline further.

We conducted a recent study to gauge the economic impact of novel nicotine products in Europe, covering vapour products, heated tobacco and nicotine pouch products. Using our own databases and trackers in addition to industry sources has enabled us to draw conclusions and insights into the current state of the market.

ETHRA November news roundup

European Tobacco Harm Reduction Advocates, ETHRA

ETHRA’s monthly roundup of news: BECA debate ‘controversial’ issue of flavours – ETHRA, Sovape & Aiduce letters to BECA  – ACPAN joins ETHRA – Vape shop support increases smoking cessation – Nicotine pouch ban – sCOPe Livestream Library – Country updates. Read on for more.

‘Build Back Deader’ with Democrats’ vape tax

Adam Sullivan, The Gazette

As a candidate last year, President Joe Biden famously promised not to raise taxes on anyone making less than $400,000. In reality, the massive spending bill under consideration by Democrats in Congress would indeed hike taxes on a bunch of poor and middle-class people.

Altria can’t sell Iqos in the U.S. as Biden administration opts to not intervene in patent dispute

Altria and Philip Morris International are no longer able to sell or import Iqos tobacco devices in the U.S. after the Biden administration opted to take no action on an ongoing patent dispute.

Rival R.J. Reynolds, a subsidiary of British American Tobacco, had filed a claim with the U.S. International Trade Commission.

On this Day…2017

Dr. Farsalinos Submits Official Complaint

Dustin Erickson, ChurnMag

Once again it’s Dr. Konstantinos Farsalinos that is fighting the good fight against false vaping information. This time he is calling into question research that was recently presented as part of the 2017 American Heart Association Scientific Sessions. The study in question was just published last week and was conducted by researchers at the University of California, San Francisco. Their report claimed to prove that the vapor produced by Heat not Burn (HnB) technology was as impactful to Flow-Mediated Dilation (FMD), as traditional tobacco smoke.

Why It Makes Sense For Altria

To Bet On The E-Cigarette Market

Cigarette smoking in the United States has dropped to the lowest level in generations, at 15.1% , according to the latest data supplied by the Centers for Disease Control and Prevention ( CDC ). The US has also witnessed the steepest decline in the smoking rate in the world. While this is good news, it has forced companies such as Altria ( MO ) to focus its efforts on looking for growth from other alternatives

Visit Nicotine Science & Policy for more News from around the World



Tagged with: , , , , , , , , , , , , , , , , , , , , ,